Promising brain metastasis combo trial halted after just one patient
Disease control
Terminated
This study aimed to see if combining three drugs (tucatinib, trastuzumab, capecitabine) with precise radiation (SRS) could safely control brain tumors from HER2+ breast cancer. Only one person enrolled before the trial was stopped early. The main goal was to find safe doses and w…
Phase: PHASE1 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated May 11, 2026 20:48 UTC